1 |
Cemdisiran
| 1件: CEMDISIRAN CEMDISIRAN | - | - | - | 4件: 11 11, 62, 66, 109 |
2 |
Crovalimab
| 1件: CROVALIMAB CROVALIMAB | 1件: D11696
D11696
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 |
3 |
Eculizumab
| 2件: Eculizumab Eculizumab; Soliris | 1件: D03940
D03940
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 11 11, 13, 14, 61, 62, 109, 222 |
4 |
Iptacopan
| 1件: Iptacopan Iptacopan | 1件: D12251
D12251
| 1件: CFB CFB 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 5件: 61 61, 62, 66, 109, 222 |
5 |
Narsoplimab
| 2件: MASP-2 antibody MASP-2 antibody; Narsoplimab | 1件: D11531
D11531
| 1件: MASP2 MASP2 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 4件: 64 64, 66, 109, 222 |
6 |
Nomacopan
| 2件: COVERSIN COVERSIN; NOMACOPAN | 1件: D11473
D11473
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 62 62, 109, 162 |
7 |
Ravulizumab
| 2件: RAVULIZUMAB RAVULIZUMAB; ULTOMIRIS | 1件: D11054
D11054
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 |